Phytosphingosine stimulates the differentiation of human keratinocytes and inhibits TPA-induced inflammatory epidermal hyperplasia in hairless mouse skin by 이승헌
INTRODUCTION
Peroxisome proliferator-activated re-
ceptors (PPARs), which are members of
the nuclear receptor family of ligand-
activated transcription factors, control
the transcription of target genes involved
in many cellular functions, including
lipid metabolism, cell proliferation, dif-
ferentiation, and inflammatory re-
sponses. The 3 PPAR isoforms, PPARα,
PPARβ⁄δ and PPARγ, have been identi-
fied in keratinocytes. PPARα and PPARγ
are expressed at low levels but their lev-
els increase dramatically during kerati-
nocyte differentiation. In contrast, the
predominant isotype, PPARβ⁄δ, is signifi-
cantly induced under conditions of ke-
ratinocyte proliferation. Substantial evi-
dence has accumulated that implicates
PPARs in the regulation of epidermal dif-
ferentiation and skin barrier homeostasis.
Administration of PPARα activators was
shown to stimulate differentiation and
inhibit proliferation in rodent keratino-
cytes (1) and to promote development of
the fetal epidermal permeability barrier
(2). Recently, it was reported that topical
treatment with PPAR agonists accelerates
the differentiation and reverses the in-
duced inflammatory hyperproliferation
of murine epidermis (3,4). These results
suggest that PPARs hold great promise
for the therapy of skin conditions charac-
terized by hyperproliferation, inflamma-
tory infiltrates, and aberrant differentia-
tion, such as psoriasis and atopic
dermatitis (5)
Sphingolipids have been shown to be
major structural components of stratum
corneum (SC) intercellular lipid bilayers,
which constitute the permeability barrier
of mammalian skin (6). In addition,
sphingolipids, including sphingoid bases
and their metabolites, are suggested to
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The binding of sphingoid bases to peroxisome proliferator-activated receptor (PPAR) has been detected in a solid-phase bind-
ing assay. However, sphingoid base–induced changes in PPAR transactivation activity have not been examined. In this report,
we show by reporter gene analyses that phytosphingosine (PS), a natural sphingoid base, activates the transcriptional activity of
PPARs in the immortalized human keratinocyte, HaCaT. Real-time PCR analyses showed that the mRNA level of PPARγ was in-
creased after PS treatment in HaCaT cells in a dose- and time-dependent manner. Because PPARs play important roles in skin
barrier homeostasis by regulating epidermal cell growth, terminal differentiation, and inflammatory response, we examined the
effect of PS on normal human epidermal keratinocytes (NHEKs) and mouse skin. PS increased the production of cornified enve-
lope in NHEKs by approximately 1.8-fold compared with controls. Epidermal differentiation marker proteins such as involucrin, lori-
crin, and keratin1 were also increased in PS-treated NHEKs, by ELISA or Western blotting analysis. A [3H]thymidine incorporation
assay showed that PS inhibited DNA synthesis in NHEKs to 20% compared with controls. The antiproliferative and anti-inflamma-
tory effects of PS were examined in a mouse model of irritant contact dermatitis produced by topical application of 12-O-
tetradecanoylphorbol-13-acetate (TPA). PS blocked epidermal thickening and edema and the infiltration of inflammatory cells
into the dermis in the skin of TPA-treated hairless mice. The anti-inflammatory effects of PS were confirmed by the observation that
PS blocked the TPA-induced generation of prostaglandin E2 in peripheral mononuclear leukocytes. Taken together, our results pro-
vide an insight into the multiple regulatory roles of PS in epidermal homeostasis, and furthermore point to the potential use of PS
as a therapeutic agent in the treatment of inflammatory and proliferative cutaneous diseases.
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act as intracellular signaling mediators in
various biological functions of the mam-
malian epidermis, such as cell growth,
differentiation, apoptosis, and inflamma-
tory responses (7-10). Among sphin-
golipids, sphingosine is known for its
anti-inflammatory and antiproliferative
activities in mouse models of irritant
contact dermatitis (7). These properties
of sphingosine were partly attributed to
its inhibitory activity on the PKC signal-
ing pathway (7). Recently, during a
search for endogenous ligands of PPARs,
the binding of sphingoid bases to PPARα
was studied in a solid-phase binding
assay that employed recombinant mouse
PPARα and a panel of different natural
and synthetic lipids immobilized on sil-
ica layers. This report suggested that
PPARs may be additional proteins that
contribute to the overall biological activi-
ties of sphingoid bases (11).
Phytosphingosine (PS) is structurally
similar to sphingosine, except that PS has
a hydroxyl group at C-4 of the sphingoid
long-chain base instead of a trans double
bond between C-4 and C-5 (Figure 1). PS
is abundant in fungi and plants (12), but
is also found in mammalian epidermis
(13). With the exception of a study of the
lipid composition of the epidermis show-
ing that psoriatic scales have reduced
amounts of PS (14), few studies have
been performed to evaluate the role of PS
in the epidermis. Kim et al. (15,16)
showed that the PS derivatives, N-acetyl
PS and tetraacetyl PS, induced pro-
grammed cell death of an immortalized
human keratinocyte cell line HaCaT and
identified genes with altered expression
in cells treated with PS derivatives. Little
is known, however, about the biological
function of PS itself in the epidermis.
In this study, we demonstrated that PS
activated the transcriptional activity of
PPARs and upregulated the expression
of PPARγ gene in HaCaT cells. PS also in-
hibited cell growth and promoted epi-
dermal differentiation in cultured normal
human epidermal keratinocytes
(NHEKs). Finally, the antiproliferative
and anti-inflammatory effects of PS on
TPA-induced inflammatory hyperplasia
of mouse skin were investigated.
MATERIALS AND METHODS
Chemicals
PS was obtained from Doosan Biotech
(Kyunggi, Korea). The purity of this
compound was 98%. All other chemicals,
unless otherwise indicated, were from
Sigma Chemical (St. Louis, MO, USA).
Cell Culture and Treatment
The spontaneously transformed human
keratinocyte cell line HaCaT was kindly
provided by Dr. N.E. Fusenig (Deutsches
Krebsforschungszentrum, Heidelberg,
Germany) (17). The cells were grown in
Dulbecco’s modified Eagle’s medium
containing 10% fetal bovine serum (FBS)
and antibiotics (100 μg streptomycin and
100 IU penicillin per mL).
NHEKs were derived from neonatal
foreskin as previously described (18).
Briefly, epidermis was isolated from
newborn foreskins by incubation in
Dispase, and a suspension of keratino-
cytes was obtained by incubation in
10 mM EDTA and subsequent trypsiniza-
tion. Cells thus obtained were cultured
with serum-free keratinocyte growth me-
dium (KGM) (Clonetics, San Diego, CA,
USA) and used for experiments after 2 or
3 passages.
Peripheral mononuclear leukocytes
were isolated using Ficoll-Paque Plus
(Amersham, Arlington Heights, IL, USA).
Diluted mouse blood (1:1 dilution with
PBS) was loaded on Ficoll-Paque and
centrifuged at 400g for 30 min. The cell
layer was then collected and incubated in
RPMI-1640 with 10% FBS at 37 °C.
For cell experiments, test compounds
were dissolved in dimethylsulfoxide
(DMSO) on the day of the experiment
and diluted with serum-free medium to
obtain the appropriate concentrations.
The final volume of vehicle was adjusted
to 0.1% (vol/vol). Control groups were
treated with the same amount of vehicle.
Plasmids and Reporter Gene Assays
The reporter plasmid containing 3
PPAR response elements (PPREs), PPRE-
tk-Luc, and the receptor expression plas-
mids, pCMX-mPPARs, have been de-
scribed previously (19,20). A modified
calcium phosphate precipitation proce-
dure was used for transient transfection
(21). Briefly, HaCaT cells (1 × 105 cells/
well) were seeded into a 12-well culture
plate and transfected with DNA mixtures
(1.3 μg/well) containing carrier DNA
(pBluescript), reporter plasmid (0.1 μg),
and the β-galactosidase (β-gal) expres-
sion vector (0.2 μg) with or without
pCMX-mPPAR expression vectors
(10 ng), using LipofectaminePlus (Gibco
BRL, Grand Island, NY, USA). The cells
were treated for 24 h with test com-
pounds. At the end of the incubation, lu-
ciferase activity was determined using a
luminometer according to the manufac-
turer’s instructions. The luciferase activ-
ity was normalized for transfection effi-
ciency using the corresponding β-gal
activity.
RNA Preparation, Reverse
Transcription, and Real-Time PCR
At the end of treatment, cells were
washed twice with Dulbecco’s phos-
phate-buffered saline (PBS), and total
RNA was isolated from cells using the
Trizol reagent (Gibco BRL Life Technolo-
gies) according to the manufacturer’s in-
structions. Four μg total RNA was re-
verse-transcribed using MuLV reverse
transcriptase (2.5 units), and the result-
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Figure 1. Structures of sphingoid bases.
ing cDNA was amplified by a thermal
cycler (ICycler; Bio-Rad, Hercules, CA,
USA) with rapid temperature control in a
50-μL reaction mixture containing
AmpliTaq DNA polymerase (0.04 units)
(Perkin Elmer, Shelton, CT, USA), 50 mM
Tris (pH 8.3), 0.25 mg/mL bovine serum
albumin, 3 mM MgCl2, 0.25 mM dNTPs,
1/50,000 dilution of SYBR Green I
(Molecular Probes, Eugene, OR, USA),
and 0.25 μM of the forward and reverse
PCR primers. The primers used for
PPARγ were forward, 5′-CAG ATC CAG
TGG TTG CAG-3’, and reverse, 5′-GTC
AGC GGA CTC TGG ATT-3′. Cycling
conditions were as follows: one denatur-
ing cycle at 95 °C for 5 min, followed by
30 cycles of 95 °C for 30 s, 53 °C for 30 s,
and 72 °C for 1 min. Relative mRNA lev-
els were determined by analyzing the
changes in SYBR Green I fluorescence
during PCR according to the manufac-
turer’s instructions with the ICycler soft-
ware. To confirm that there was no fluo-
rescence resulting from either genomic
DNA contamination or reverse transcrip-
tion, RNA (1 to 3 μg) without reverse
transcriptase was analyzed in triplicate.
Each PCR run also included triplicate
wells of no template control where
RNase-free water was added to reaction
wells. β-Actin was amplified in parallel,
and the results were used for normaliza-
tion, as previously described (22). The
size of PCR product was confirmed by
electrophoresis on a 1% agarose gel
stained with ethidium bromide. Purity of
the amplified PCR products was deter-
mined by melting point analysis using
ICycler software.
Quantitation of Cornified Envelope
Cornified envelope (CE) content of
cultured keratinocytes was determined
using a previously described method
(23). Briefly, NHEKs were treated for 
7 days with either CaCl2 or test com-
pounds at the indicated concentrations
and harvested in 2% SDS solution.
After slight sonication (5 s), aliquots
were removed for protein determina-
tion. The lysate was centrifuged at
12,000 rpm for 15 min and resuspended
in 2% SDS/20 mM dithiothreitol (DTT)
and boiled for 1 h, and the amounts of
soluble cross-linked envelopes were
quantified by spectrophotometry at
310 nm.
Involucrin Assay
The amount of involucrin in NHEK
cultures was determined as previously
described (24). Briefly, following 4 days
of treatment with either CaCl2 or test
compounds at the indicated concentra-
tions, cells were harvested and homoge-
nized. After microcentrifugation at
12,000 rpm for 15 min, supernatants
were analyzed for involucrin using an
enzyme-linked immunosorbent assay
(ELISA) kit (Biomedical Technologies,
Stoughton, MA, USA)
Western Blotting
At the end of the treatment with test
compounds, NHEK cells were lysed in a
lysis buffer consisting of 8 M urea, 2%
CHAPS, 50 mM DTT, 2 M thiourea,
2 mM PMSF, 100 μg/mL leupeptine,
and 25 μg/mL aprotinin. The lysate was
then subjected to centrifugation at
15,000g for 10 min, and the supernatant
was used for Western blot analysis.
Protein concentrations were determined
by the Bradford method using bovine
serum albumin as the standard. Proteins
(80 μg per well) were fractionated by
SDS-PAGE and transferred to nitrocellu-
lose membrane. The membrane was
blocked with 5% skim milk in TBST
(10 mM Tris-HCl, pH 8.0, 150 mM NaCl,
0.15% Tween-20) for 1 h at room tem-
perature and subsequently probed
overnight at 4°C with antiloricrin (1:500
dilution in TBST containing 5% skim
milk) or anti-K1 antibodies (1:500 dilu-
tion in TBST containing 5% skim milk)
(BabCo, Berkeley, CA, USA). Blots were
washed 3 times with TBST and incu-
bated with horseradish peroxidase–
conjugated goat anti-rabbit IgG (Bio-Rad)
at 1:1000 dilution at room temperature
for 1 h. Detection was performed with
the ECL system (Amersham Pharmacia
Biotech, Piscataway, NJ, USA). The rela-
tive protein levels were analyzed using
ImageMaster 2D Elite software (Amer-
sham Biosciences, Buckinghamshire, UK).
β-Actin was used as a loading control.
[3H]Thymidine Incorporation Assay
NHEKs grown to 70% confluence in
24-well plates were treated in triplicate
with vehicle or test compounds for 24
h. Four hours before harvesting, cells
were pulsed with 1 mCi/mL [3H]thymi-
dine (2 Ci/mM; New England Nuclear,
Boston, MA, USA). The medium was
removed, and the cells were washed
twice with ice-cold PBS. Cells were then
incubated on ice with ice-cold 10%
(wt/vol) trichloroacetic acid once for
10 min and then twice for 5 min to fix
cells and precipitate DNA. The cells
were lysed with 1 mL/well lysis buffer
containing 0.3 N NaOH and 1% SDS for
15 min at room temperature. Cell
lysates were transferred to scintillation
vials containing 5 mL scintillation liq-
uid and mixed well. [3H]thymidine ra-
dioactivity was measured, and the val-
ues were normalized with respect to the
protein concentration.
Animal Treatment and Tissue
Preparation
This study was conducted in conform-
ity with the policies and procedures of
the Institutional Animal Care and Use
Committee of AmorePacific Corporation
R&D Center. Hos:hr-1 albino male hair-
less mice and male ICR mice, purchased
from Biogenomics (Seoul, Korea) at 7
weeks of age, were used for this study.
The backs of hairless mice or the ears
of ICR mice were treated with TPA
(10 nmoles in acetone) and then divided
into 3 groups (n = 7). Each group of mice
was treated with vehicle (ethanol:propy-
lene glycol, 7:3), PS (20 μmoles), or trogli-
tazone (20 μmoles) for 30 min after TPA
treatment. The hairless mice were killed
3 days after the single treatment, and 4-mm
punch biopsies were taken and embed-
ded in paraffin. Five cross-sections were
taken from each tissue and stained with
H&E. Stained slides were quantitatively
characterized via digital image analysis
using ImagePro-Plus (Media Cybernetics,
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Silver Spring, MD, USA). Images were
captured through an Olympus BH-2 mi-
croscope fitted with a MicroImage video
camera (Boyertown, PA, USA).
Parameters such as area of epidermis
and length of basement membrane were
taken from a series of 10 random images
on several slides to obtain a mean value
for statistical comparison. Epidermal
thickness was determined by the follow-
ing formula: area of epidermis/length of
basement membrane. Similarly, 4-mm
full skin biopsies from the ears of ICR
mice were taken for measurement of
weight and myeloperoxidase (MPO)
activity.
MPO Assay
MPO activity was determined using
the supernatants from the homogenates
of the ear biopsy (25,26). The tissues
were placed in 1.5 mL of 50 mM sodium
phosphate buffer, pH 6.0, containing
0.5% hexadecyltrimethylammonium
bromide (HTAB) and homogenized for
45 s at 0 °C in a motor-driven homoge-
nizer (Polytron PT 1200; Kinematica,
Cincinnati, OH, USA). For the assay
of MPO, we followed the method of
Bradley et al. (26). Briefly, 50 μL super-
natant, 50 μL phosphate buffer, pH 6.0,
containing 0.5% HTAB, and 50 μL o-dian-
isidine solution (0.68 mg/mL in distilled
water) were added into the wells of a 96-
well microtiter plate, and the reaction
was started by adding 50 μL freshly pre-
pared 0.003% hydrogen peroxide. The
optical density at 450 nm was read im-
mediately and thereafter at 5-min inter-
vals. The enzyme activity in the samples
was obtained by comparing the rate of
the reaction with that in wells containing
supernatant from the control group
treated only with TPA.
Prostaglandin E2 Assay
Mouse peripheral mononuclear
leukocytes were cultured in 96-well
plates (2 × 105 cells/well). After prein-
cubation with TPA (16 nM) for 2 h, the
cells were treated with either the cy-
clooxygenase inhibitor, indomethacin
(1 nM and 10 nM), PS (5μΜ), or troglita-
zone (TGZ, 5 μΜ) for 16 h. The pros-
taglandin E2 (PGE2) concentration was
measured using an enzyme immuno-
assay (EIA) kit (Cayman Chemical, Ann
Arbor, MI, USA) according to the man-
ufacturer’s instructions.
Statistics
The ANOVA test was performed
using SigmaStat (SPSS, Chicago, IL,
USA). The results were considered sig-
nificant at P < 0.05.
RESULTS
Phytosphingosine Increased the
Transcriptional Activity of PPARs and
the Expression of PPARγ Gene
We tested whether known PPAR lig-
ands and PS could activate the transcrip-
tional activity of endogenous PPARs in
HaCaT cells using transient transfection
experiments employing the PPRE-tk-Luc
reporter gene containing 3 PPAR re-
sponse elements (19). When PPRE-tk-Luc
was transfected into HaCaT cells, the
synthetic PPARγ ligand troglitazone
(TGZ) and PS at 1 μM induced reporter
activity by approximately 3.0- and 2.0-
fold, respectively, whereas the PPARα ac-
tivator WY-14643 and the putative
PPARβ/δ agonist prostacyclin (PGI2) had
no effect (Figure 2A). When the reporter
gene was cotransfected with PPARα,
PPARβ/δ, and PPARγ expression vectors,
PS at 1 μM increased reporter activity by
approximately 36%, 17%, and 57%, re-
spectively (Figure 2B). These results sug-
gested that PPARγ acts as a dominantly
active PPAR isoform in HaCaT cells and
that PS can increase the transcriptional
activity of PPARs with or without ectopic
expression of PPAR isotypes.
Next, we examined the effect of PS on
the expression of PPARγ gene, because
previous studies showed that the activa-
tion of PPARγ by TGZ increased PPARγ
gene expression in several cultured cell
lines (27). As shown in Figure 2C and D,
mRNA level of PPARγ was increased
after PS treatment in HaCaT cells in a
dose- and time-dependent manner. A
maximum of 3.8-fold was obtained with
5 μM concentration after 24-h treatment
(Figure 2C,D).
Phytosphingosine Inhibited the
Proliferation and Stimulated the
Differentiation of Human Epidermal
Keratinocytes
When proliferating keratinocytes are
induced to differentiate in vitro by treat-
ing with PPAR activators or by changing
the calcium ion concentration in the cul-
ture medium, the expression of differen-
tiation-specific proteins, such as involu-
crin, loricrin, and K1, is induced and the
amount of insoluble CEs is increased
(1,28). To determine the effect of PS on
keratinocyte differentiation, NHEK cells
grown in low-calcium medium (0.05 mM
CaCl2) were shifted to high-calcium me-
dium (1.5 mM CaCl2) or treated with
TGZ or PS, and cultured for an addi-
tional 4 or 7 days before harvesting. As
shown in Figure 3A, treatment of kerati-
nocytes with 5 μM PS for 7 days in-
creased the production of CE by approxi-
mately 1.9-fold, which was similar to
that seen with TGZ. When examined by
ELISA, the level of involucrin increased
by about 40% after exposure to 5 μM PS
for 4 days (Figure 3B). The level of in-
volucrin in keratinocytes treated with PS
was comparable to that of cells cultured
in high-calcium medium. The levels of
loricrin and K1 as measured by Western
blotting analysis were also significantly
increased by treatment with 5 μM PS
(Figure 3C).
The differentiation of keratinocytes is
often accompanied by the inhibition of
proliferation. To determine whether PS
has an inhibitory effect on keratinocyte
growth, the rate of DNA synthesis was
measured by the [3H]thymidine incor-
poration assay. PS at 5 μM decreased
[3H]thymidine incorporation into DNA
by 80%, compared with the control
(Figure 3D). The antiproliferative effect
of PS was not due to cytotoxicity—the
MTT assay and microscopic evaluation
of keratinocytes treated with PS at a
concentration of 5 μM did not reveal
any signs of cytotoxicity (data not
shown).
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These results demonstrate that PS in-
duces the differentiation and inhibits




Inflammation in Mouse Skin
Antiproliferative and prodifferentiating
effects of PPAR activators have been eval-
uated in a murine model of irritant con-
tact dermatitis, where epidermal hyper-
plasia by topical treatment with TPA
reproduced some of the abnormalities of
several common skin disorders (29).
Topical treatment with PPAR agonists has
been shown to result in a marked de-
crease in epidermal hyperplasia and a re-
duction in the number of inflammatory
cells in the dermis. In the same murine
model, we assessed the antiproliferative
and anti-inflammatory effects of PS. First,
we examined H&E-stained sections of the
back skins from TPA-treated hairless
mice. As shown in Figure 4A and E, the
epidermal thickness of the hairless mouse
skin increased by about 2-fold 3 days after
TPA treatment. In animals treated with
TPA together with PS or TGZ, the epider-
mis was thinner than in animals treated
with TPA alone (Figure 4B,C,E). Similarly,
PS reduced the TPA-induced increase in
the ear weight of ICR mice (Figure 5). The
MPO activity of TPA-treated ear samples
was also strongly reduced by cotreatment
with PS (Figure 5), indicating that PS has
strong inhibitory effects on the cellular
migration of polymorphonuclear leuko-
cytes. Taken together, these results indi-
cate that PS treatment inhibits epidermal
hyperplasia and inflammation by a mag-
nitude similar to that seen with TGZ.
Phytosphingosine Reduced TPA-
Induced PGE2 Secretion from
Mononuclear Leukocytes
We next examined whether PS affects
on TPA-induced production of the in-
flammatory mediator, PGE2, which is
known as to modulate the production of
proinflammatory cytokines and to sus-
tain local and systemic inflammatory re-
sponses (30,31). As shown in Figure 6,
TPA induced a significant increase in
PGE2 production. PS at 5 μM inhibited
PGE2 production by 38%.
DISCUSSION
The activities of sphingolipids as sig-
naling modulators in the epidermis have
been studied extensively. In spite of their
structural similarity to sphingosine, how-
ever, the physiological roles of PS in the
epidermis are still largely unknown. To
date, PS has been shown to induce apop-
tosis in human cancer cells (32,33).
Considering that terminal differentiation
of keratinocytes has been suggested to be
a specialized form of apoptosis (34,35),
one action of exogenously supplied PS
on keratinocytes might be the induction
of the cellular and molecular events that
are shared by keratinocyte differentiation
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Figure 2. The effect of phytosphingosine on the transcriptional activity of PPARs and the
expression of PPARγ gene. PPRE-tk-Luc was transiently transfected (A) or cotransfected
with 10 ng of the pCMX-mPPAR expression vector into HaCaT cells (B) as described in
“Materials and Methods.” Transfected cells were treated with WY14643, prostacyclin
(PGI2), troglitazone (TGZ), or phytosphingosine (PS) as indicated and assayed 24 h later
for luciferase activity. The corresponding β-gal activity was used to normalize luciferase
activity. HaCaT cells were treated with indicated concentrations of phytosphingosine (PS)
or 10 μM troglitazone (TGZ) for 24 h (C) or treated with 5 μM PS for the indicated time pe-
riods (D). At the end of incubation, total RNA was isolated and mRNA levels of PPARγ
were measured by quantitative real-time RT-PCR analysis as described in “Materials and
Methods.” The mRNA level of PPARγ in vehicle control or control at 0 h was set at 1, and
the relative expression levels are presented as fold induction compared with that of each
control. Data represent the mean ± SD of 3 or 4 independent experiments. *Significant at
P < 0.05. **Significant at P < 0.01.
and apoptosis. From this point of view,
we tried to elucidate the regulatory roles
of PS in keratinocyte differentiation and
skin barrier homeostasis.
First, we examined whether PS acti-
vates the transcriptional activity of
PPARs in immortalized human keratino-
cyte HaCaT cells using transient trans-
fection experiments. Previously, the in-
teraction between sphingoid bases and
PPARα in a solid-phase binding assay
suggested that PPARs might be proteins
that contribute to the overall biological
activity of sphingoid bases (11). Further-
more, the PPAR family is one of the
most extensively investigated nuclear re-
ceptor families and has been implicated
in the maintenance of epidermal homeo-
stasis. We found that PS activated the
transcriptional activity of PPARs in
HaCaT cells to an extent comparable to
that of the synthetic PPARγ ligand TGZ.
Because the activation of PPARγ results
in upregulation of PPARγ gene expres-
sion (27), we examined the effect of PS
on the expression of PPARγ gene. Real-
time PCR analyses showed that the
mRNA level of PPARγ was increased
after PS treatment in HaCaT cells in a
dose- and time-dependent manner.
Next, the effect of PS on the differenti-
ation of cultured NHEKs was examined.
Because CE, involucrin, loricrin, and K1
are well-characterized markers of kerati-
nocyte differentiation (23,36,37), we ex-
amined whether these markers were in-
creased by PS treatment. As expected, PS
treatment caused significant increases in
CE formation and in involucrin, loricrin,
and K1 protein levels in NHEKs cultured
in low-calcium, serum-free medium.
Keratinocyte differentiation induced by
PS was accompanied by growth inhibi-
tion, as determined by the [3H]thymidine
incorporation assay. These results dem-
onstrate that PS promotes differentiation
and inhibits the proliferation of NHEKs
in vitro.
We also investigated the antiprolifera-
tive and anti-inflammatory effects of PS
on TPA-induced inflammation and epi-
dermal hyperproliferation in mouse skin,
because PPAR activators have been
shown to be potent inhibitors of TPA-in-
duced inflammatory hyperplasia re-
sponses (29). The histological alterations
induced by TPA in mouse skin were simi-
lar to those reported in other studies
(7,38). TPA treatment resulted in a
marked increase in the epidermal thick-
ness of hairless mouse skin. The ear
weight of ICR mice was also markedly
increased following TPA treatment.
Treatment with PS greatly reduced the
magnitude of TPA-induced increases in
epidermal thickness and ear weight.
MPO activity, which indicates the infiltra-
tion of polymorphonuclear leukocytes
into skin, was increased in TPA-treated
ears but dramatically reduced in ears
cotreated with TPA and PS. Furstenberger
and Marks (39) reported that the level of
PGE2 increased shortly after topical TPA
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Figure 3. The effect of phytosphingosine on the proliferation and differentiation of kerati-
nocytes. (A) For the measurement of cornified envelope (CE) content, normal human
epidermal keratinocytes were treated for 7 days with Ca2+ (1.5 mM), phytosphingosine
(PS), or troglitazone (TGZ) at the concentrations indicated. CEs were extracted by ex-
haustive boiling followed by sonication and quantification by spectrophotometry at
310 nm. Data are means ± SD of 3 independent experiments. *Significant at P < 0.05.
(B and C) To measure epidermal differentiation marker proteins, normal human epider-
mal keratinocytes were treated for 4 days with high Ca2+ (1.5 mM), 5 μM phytosphingo-
sine (PS), or 5 μM troglitazone (TGZ). The level of involucrin was analyzed by ELISA. Data
are means ± SD of 3 independent experiments. *Significant at P < 0.05. The expression of
loricrin and keratin1 was assessed by immunoblotting with antiloricrin or antikeratin1 anti-
body. The relative densitometric ratios are indicated. The data are representative of 3
independent blots. (D) Normal human epidermal keratinocytes in 24-well plates were
treated with the indicated concentrations of phytosphingosine (PS). [3H]thymidine
(1 μCi) was added to the wells 20 h after the addition of PS, the plates were incubated
for 4 h, and the amount of cell-associated radioactivity was quantified. The indicated
DNA synthesis levels are the means of the levels of triplicate wells ± SD expressed as a
percent of the control. The DNA synthesis rate for the control was 1,570,072 ± 141,322
cpm/well. *Significant at P < 0.01.
treatment and that this early increase in
PGE2 content appeared to be an impor-
tant mediator of the pleiotypic response
to TPA in the mouse skin. To examine
whether PS interfered with TPA by in-
hibiting PGE2 synthesis, the effect of PS
on the TPA-induced PGE2 synthesis in
mouse peripheral mononuclear leuko-
cytes was examined in cell culture. PGE2
production by TPA was blocked dramati-
cally by treatment with PS. These results
indicate that PS is a potent inhibitor of
TPA-induced inflammatory hyperplasia.
In summary, we have shown that PS
activates the transcriptional activity of
PPARs and subsequently promotes the
differentiation and growth arrest of ke-
ratinocytes in vitro. In addition, PS pre-
vents TPA-induced inflammatory hyper-
plasia in hairless mouse skin. Our results
suggest that PS treatment could be of a
therapeutic benefit in a variety of inflam-
matory and hyperproliferative cutaneous
diseases.
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